RNA Dimerization Promotes PKR Dimerization and Activation

Journal of Molecular Biology

Volumn 390, Issue 2, 2009, Pages 319-338

  Heinicke, Laurie A ^a   Wong, C Jason ^b   Lary, Jeffrey ^b   Nallagatla, Subba Rao ^a   Diegelman Parente, Amy ^c   Zheng, Xiaofeng ^d   Cole, James L ^b   Bevilacqua, Philip C ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d PEKING UNIVERSITY   (China)

Author keywords

analytical ultracentrifugation; innate immunity; protein kinase; RNA folding; RNA protein interaction

Indexed keywords

DOUBLE STRANDED RNA; INITIATION FACTOR 2ALPHA; PROTEIN KINASE R; RNA; SHORT HAIRPIN RNA;

ARTICLE; AUTOPHOSPHORYLATION; BASE PAIRING; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; HUMAN IMMUNODEFICIENCY VIRUS 1; INNATE IMMUNITY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; STOICHIOMETRY; TRANSACTIVATION; ULTRACENTRIFUGATION;

EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 67349188739     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.05.005     Document Type: Article

References (64)

1. Katze M.G., He Y., and Gale Jr. M. Viruses and interferon: a fight for supremacy. Nat. Rev., Immunol. 2 (2002) 675-687
2. Langland J.O., Cameron J.M., Heck M.C., Jancovich J.K., and Jacobs B.L. Inhibition of PKR by RNA and DNA viruses. Virus Res. 119 (2006) 100-110
3. Rothenburg S., Seo E.J., Gibbs J.S., Dever T.E., and Dittmar K. Rapid evolution of protein kinase PKR alters sensitivity to viral inhibitors. Nat. Struct. Mol. Biol. 16 (2009) 63-70
4. Weber F., Wagner V., Rasmussen S.B., Hartmann R., and Paludan S.R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80 (2006) 5059-5064
5. Nanduri S., Carpick B.W., Yang Y., Williams B.R., and Qin J. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. EMBO J. 17 (1998) 5458-5465
6. Dar A.C., Dever T.E., and Sicheri F. Higher-order substrate recognition of eIF2α by the RNA-dependent protein kinase PKR. Cell 122 (2005) 887-900
7. McKenna S.A., Lindhout D.A., Kim I., Liu C.W., Gelev M., Wagner G., and Puglisi J.D. Molecular framework for the activation of RNA-dependent protein kinase. J. Biol. Chem. 282 (2007) 11474-11486
8. Vanoudenhove J., Anderson E., Kreuger S., and Cole J.L. Analysis of PKR structure by small angle scattering. J. Mol. Biol. 387 (2009) 910-920
9. Cole J.L. Activation of PKR: an open and shut case?. Trends Biochem. Sci. 32 (2007) 57-62
10. Minks M.A., West D.K., Benvin S., and Baglioni C. Structural requirements of double-stranded RNA for the activation of 2′,5′-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells. J. Biol. Chem. 254 (1979) 10180-10183
11. Manche L., Green S.R., Schmedt C., and Mathews M.B. Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol. Cell. Biol. 12 (1992) 5238-5248
12. Kostura M., and Mathews M.B. Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI. Mol. Cell. Biol. 9 (1989) 1576-1586
13. Schmedt C., Green S.R., Manche L., Taylor D.R., Ma Y., and Mathews M.B. Functional characterization of the RNA-binding domain and motif of the double-stranded RNA-dependent protein kinase DAI (PKR). J. Mol. Biol. 249 (1995) 29-44
14. Bevilacqua P.C., and Cech T.R. Minor-groove recognition of double-stranded RNA by the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR. Biochemistry 35 (1996) 9983-9994
15. Ucci J.W., Kobayashi Y., Choi G., Alexandrescu A.T., and Cole J.L. Mechanism of interaction of the double-stranded RNA (dsRNA) binding domain of protein kinase R with short dsRNA sequences. Biochemistry 46 (2007) 55-65
16. Lemaire P.A., Anderson E., Lary J., and Cole J.L. Mechanism of PKR activation by dsRNA. J. Mol. Biol. 381 (2008) 351-360
17. Lemaire P.A., Lary J., and Cole J.L. Mechanism of PKR activation: dimerization and kinase activation in the absence of double-stranded RNA. J. Mol. Biol. 345 (2005) 81-90
18. Nallagatla S.R., and Bevilacqua P.C. Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner. RNA 14 (2008) 1201-1213
19. Bevilacqua P.C., George C.X., Samuel C.E., and Cech T.R. Binding of the protein kinase PKR to RNAs with secondary structure defects: role of the tandem A-G mismatch and noncontiguous helixes. Biochemistry 37 (1998) 6303-6316
20. Zheng X., and Bevilacqua P.C. Activation of the protein kinase PKR by short double-stranded RNAs with single-stranded tails. RNA 10 (2004) 1934-1945
21. Ben-Asouli Y., Banai Y., Pel-Or Y., Shir A., and Kaempfer R. Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell 108 (2002) 221-232
22. Edery I., Petryshyn R., and Sonenberg N. Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: a novel translational control mechanism. Cell 56 (1989) 303-312
23. SenGupta D.N., and Silverman R.H. Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA. Nucleic Acids Res. 17 (1989) 969-978
24. SenGupta D.N., Berkhout B., Gatignol A., Zhou A.M., and Silverman R.H. Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 87 (1990) 7492-7496
25. Gunnery S., Rice A.P., Robertson H.D., and Mathews M.B. Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded RNA-activated protein kinase. Proc. Natl Acad. Sci. USA 87 (1990) 8687-8691
26. Gunnery S., Green S.R., and Mathews M.B. Tat-responsive region RNA of human immunodeficiency virus type 1 stimulates protein synthesis in vivo and in vitro: relationship between structure and function. Proc. Natl Acad. Sci. USA 89 (1992) 11557-11561
27. Maitra R.K., McMillan N.A.J., Desai S., McSwiggen J., Hovanessian A.G., Sen G., et al. HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology 204 (1994) 823-827
28. Nekhai S., Kuman A., Bottaro D.P., and Petryshyn R. Peptides derived from the interferon-induced PKR prevent activation by HIV-1 TAR RNA. Virology 222 (1996) 193-200
29. Carpick B.W., Graziano V., Schneider D., Maitra R.K., Lee X., and Williams B.R.G. Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-I trans-activating region RNA. J. Biol. Chem. 272 (1997) 9510-9516
30. Spanggord R.J., Vuyisich M., and Beal P.A. Identification of binding sites for both dsRBMs of PKR on kinase-activating and kinase-inhibiting RNA ligands. Biochemistry 41 (2002) 4511-4520
31. McKenna S.A., Kim I., Liu C.W., and Puglisi J.D. Uncoupling of RNA binding and PKR kinase activation by viral inhibitor RNAs. J. Mol. Biol. 358 (2006) 1270-1285
32. McKenna S.A., Lindhout D.A., Shimoike T., Aitken C.E., and Puglisi J.D. Viral dsRNA inhibitors prevent self-association and autophosphorylation of PKR. J. Mol. Biol. 372 (2007) 103-113
33. Puglisi J.D., Tan R., Calnan B.J., Frankel A.D., and Williamson J.R. Conformation of the TAR RNA-arginine complex by NMR spectroscopy. Science 257 (1992) 76-80
34. Andersen E.S., Contera S.A., Knudsen B., Damgaard C.K., Besenbacher F., and Kjems J. Role of the trans-activation response element in dimerization of HIV-1 RNA. J. Biol. Chem. 279 (2004) 22243-22249
35. Chen C., Sheng S., Shao Z., and Guo P. A dimer as a building block in assembling RNA. A hexamer that gears bacterial virus phi29 DNA-translocating machinery. J. Biol. Chem. 275 (2000) 17510-17516
36. Muriaux D., Fossé P., and Paoletti J. A kissing complex together with a stable dimer is involved in the HIV-1Lai RNA dimerization process in vitro. Biochemistry 35 (1996) 5075-5082
37. Fang G., and Cech T.R. Oxytricha telomere-binding protein: DNA-dependent dimerization of the α and β subunits. Proc. Natl Acad. Sci. USA 90 (1993) 6056-6060
38. Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys. J. 78 (2000) 1606-1619
39. Stafford W.F., and Sherwood P.J. Analysis of heterologous interacting systems by sedimentation velocity: curve fitting algorithms for estimation of sedimentation coefficients, equilibrium and kinetic constants. Biophys. Chem. 108 (2004) 231-243
40. Stafford III W.F. Boundary analysis in sedimentation transport experiments: a procedure for obtaining sedimentation coefficient distributions using the time derivative of the concentration profile. Anal. Biochem. 203 (1992) 295-301
41. McGhee J.D., and von Hippel P.H. Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice. J. Mol. Biol. 86 (1974) 469-489
42. Riordan F.A., Bhattacharyya A., McAteer S., and Lilley D.M. Kinking of RNA helices by bulged bases, and the structure of the human immunodeficiency virus transactivator response element. J. Mol. Biol. 226 (1992) 305-310
43. Muesing M.A., Smith D.H., and Capon D.J. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 48 (1987) 691-701
44. Berkhout B., Silverman R.H., and Jeang K.T. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 59 (1989) 273-282
45. Markham N.R., and Zuker M. UNAFold: software for nucleic acid folding and hybridization. Methods Mol. Biol. 453 (2008) 3-31
46. Lockard R.E., and Kumar A. Mapping tRNA structure in solution using double-strand-specific ribonuclease V1 from cobra venom. Nucleic Acids Res. 9 (1981) 5125-5140
47. Lowman H.B., and Draper D.E. On the recognition of helical RNA by cobra venom V1 nuclease. J. Biol. Chem. 261 (1986) 5396-5403
48. Ehresmann C., Baudin F., Mougel M., Romby P., Ebel J.P., and Ehresmann B. Probing the structure of RNAs in solution. Nucleic Acids Res. 15 (1987) 9109-9128
49. Kierzek R., Burkard M.E., and Turner D.H. Thermodynamics of single mismatches in RNA duplexes. Biochemistry 38 (1999) 14214-14223
50. Mellits K.H., Pe'ery T., Manche L., Robertson H.D., and Mathews M.B. Removal of double-stranded contaminants from RNA transcripts: synthesis of adenovirus VA RNAI from a T7 vector. Nucleic Acids Res. 18 (1990) 5401-5406
51. Puglisi J.D., Chen L., Blanchard S., and Frankel A.D. Solution structure of a bovine immunodeficiency virus Tat-TAR peptide-RNA complex. Science 270 (1995) 1200-1203
52. Kim I., Liu C.W., and Puglisi J.D. Specific recognition of HIV TAR RNA by the dsRNA binding domains (dsRBD1-dsRBD2) of PKR. J. Mol. Biol. 358 (2006) 430-442
53. Ucci J.W., and Cole J.L. Global analysis of non-specific protein-nucleic interactions by sedimentation equilibrium. Biophys. Chem. 108 (2004) 127-140
54. Nallagatla S.R., Toroney R., and Bevilacqua P.C. A brilliant disguise for self RNA: 5′-end and internal modifications of primary transcripts suppress elements of innate immunity. RNA Biol. 5 (2008) 25-29
55. Ouellet D.L., Plante I., Landry P., Barat C., Janelle M.E., Flamand L., et al. Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res. 36 (2008) 2353-2365
56. Andersen E.S., Jeeninga R.E., Damgaard C.K., Berkhout B., and Kjems J. Dimerization and template switching in the 5′ untranslated region between various subtypes of human immunodeficiency virus type 1. J. Virol. 77 (2003) 3020-3030
57. Paillart J.C., Shehu-Xhilaga M., Marquet R., and Mak J. Dimerization of retroviral RNA genomes: an inseparable pair. Nat. Rev., Microbiol. 2 (2004) 461-472
58. Wilkinson K.A., Gorelick R.J., Vasa S.M., Guex N., Rein A., Mathews D.H., et al. High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological states. PLoS Biol. 6 (2008) e96
59. Das A.T., Harwig A., Vrolijk M.M., and Berkhout B. The TAR hairpin of human immunodeficiency virus type 1 can be deleted when not required for Tat-mediated activation of transcription. J. Virol. 81 (2007) 7742-7748
60. Nallagatla S.R., Hwang J., Toroney R., Zheng X., Cameron C.E., and Bevilacqua P.C. 5′-Triphosphate-dependent activation of PKR by RNAs with short stem-loops. Science 318 (2007) 1455-1458
61. Sadowski I., Ma J., Triezenberg S., and Ptashne M. GAL4-VP16 is an unusually potent transcriptional activator. Nature 335 (1988) 563-564
62. Milligan J.F., and Uhlenbeck O.C. Synthesis of small RNAs using T7 RNA polymerase. Methods Enzymol. 180 (1989) 51-62
63. Zheng X., and Bevilacqua P.C. Straightening of bulged RNA by the double-stranded RNA-binding domain from the protein kinase PKR. Proc. Natl Acad. Sci. USA 97 (2000) 14162-14167
64. Philo J.S. Improved methods for fitting sedimentation coefficient distributions derived by time-derivative techniques. Anal. Biochem. 354 (2006) 238-246